UBS lowered the target price for Wuxi Bio (02269) to HKD16.6 from HKD17.6 and maintained the "neutral" rating.
The research house said it fine-tuned its model and trimmed 2024/25 EPS estimates by 7.3%/6.3%.
《說說心理話》與你分享被性騷擾解決辦法,大量真實個案,唔同場所如何提防及應對?► 即睇